Orbital Kondo Effect in Cex_xLa1−x_{1-x}B6_6: Scaling Analysis

Peculiarity of the Kondo effect in Ce$_x$La$_{1-x}$B$_6$ is investigated on the basis of the scaling equations up to third order. For the case where the $f^1$-$f^2$ charge fluctuation enters in addition to the $f^1$-$f^0$ one, the effective exchange interaction becomes anisotropic with respect to the orbital pseudospins which represent the two different orbitals in the $\Gamma_8$ ground state. Because of different characteristic energies for electric and magnetic tensors, scaling with the single Kondo temperature does not apply to physical quantities such as the resistivity and magnetic susceptibility. Possibility of a bizzare phase is pointed out where the RKKY interaction leads to the spin ordering without orbital ordering. This phase serves as a candidate of the phase IV which is observed to be isotropic magnetically.Comment: 10 pages, 4 eps figures, submitted to PR

Scaling analysis of a model Hamiltonian for Ce3+^{3+} impurity in a cubic metal

We introduce various exchange interactions in a model Hamiltonian for Ce$^{3+}$ ions in cubic symmetry with three configurations ($f^0$,$f^1$,$f^2$). With the impurity pseudo spin $S_I=1/2$, our Hamiltonian includes: (i) One-channel $S_c=1/2$ Anderson model; (ii) Two-channel $S_c=1/2$ Anderson model; (iii) An unforseen one-channel $S_c=3/2$ Anderson model with a non-trivial fixed point; (iv) Mixing exchange interaction between the $\Gamma_{6,7}$ and the $\Gamma_8$ conduction electron partial wave states; (v) Multiple conduction electron partial wave states. Using the third-order scaling (perturbative renormalization group) analysis, we study stability of various fixed points relevant to various exchange interactions for Ce$^{3+}$ ions in cubic symmetry.Comment: 68 pages. 4 figures are available upon request from [email protected] (revised

Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort study in England

: Background: Immunocompromised individuals are at increased risk of severe COVID-19 outcomes, underscoring the importance of COVID-19 vaccination in this population. The lack of comprehensive real-world data on vaccine uptake, effectiveness and safety in these individuals presents a critical knowledge gap, highlighting the urgency to better understand and address the unique challenges faced by immunocompromised individuals in the context of COVID-19 vaccination. Methods: We analysed data from 12,274,946 people in the UK aged > 12 years from 01/12/2020 to 11/04/2022. Of these, 583,541 (4.8%) were immunocompromised due to immunosuppressive drugs, organ transplants, dialysis or chemotherapy. We undertook a cohort analysis to determine COVID-19 vaccine uptake, nested case–control analyses adjusted for comorbidities and sociodemographic characteristics to determine effectiveness of vaccination against COVID-19 hospitalisation, ICU admission and death, and a self-controlled case series assessing vaccine safety for pre-specified adverse events of interest. Results: Overall, 93.7% of immunocompromised individuals received at least one COVID-19 vaccine dose, with 80.4% having received three or more doses. Uptake reduced with increasing deprivation (hazard ratio [HR] 0.78 [95%CI 0.77–0.79] in the most deprived quintile compared to the least deprived quintile for the first dose). Estimated vaccine effectiveness against COVID-19 hospitalisation 2–6 weeks after the second and third doses compared to unvaccinated was 78% (95%CI 72–83) and 91% (95%CI 88–93) in the immunocompromised population, versus 85% (95%CI 83–86) and 86% (95%CI 85–89), respectively, for the general population. Results showed COVID-19 vaccines were protective against intensive care unit (ICU) admission and death in both populations, with effectiveness of over 92% against COVID-19-related death and up to 95% in reducing ICU admissions for both populations following the third dose. COVID-19 vaccines were generally safe for immunocompromised individuals, though specific doses of ChAdOx1, mRNA-1273 and BNT162b2 raised risks of specific cardiovascular/neurological conditions. Conclusions: COVID-19 vaccine uptake is high in immunocompromised individuals on immunosuppressive drug therapy or who have undergone transplantation procedures, with documented disparities by deprivation. Findings suggest that COVID-19 vaccines are protective against severe COVID-19 outcomes in this vulnerable population, and show a similar safety profile in immunocompromised individuals and the general population, despite some increased risk of adverse events. These results underscore the importance of ongoing vaccination prioritisation for this clinically at-risk population to maximise protection against severe COVID-19 outcomes

Hidden non-Fermi liquid behavior due to crystal field quartet

We study a realistic Kondo model for crystal field quartet ground states having magnetic and non-magnetic (quadrupolar) exchange couplings with conduction electrons, using the numerical renormalization group method. We focus on a local effect dependent on singlet excited states coupled to the quartet, which reduces the non-magnetic coupling significantly and drives non-Fermi liquid behavior observed in the calculated quadrupolar susceptibility. A crossover from the non-Fermi liquid state to the Fermi liquid state is characterized by a small energy scale very sensitive to the non-magnetic coupling. On the other hand, the Kondo temperature observed in the magnetic susceptibility is less sensitive. The different crystal-field dependence of the two exchange couplings may be related to the different $x$ dependence of quadrupolar and magnetic ordering temperatures in Ce$_x$La$_{1-x}$B$_6$.Comment: 7 pages, 5 EPS figures, REVTe

Multivariate proteomic profiling identifies novel accessory proteins of coated vesicles.

Despite recent advances in mass spectrometry, proteomic characterization of transport vesicles remains challenging. Here, we describe a multivariate proteomics approach to analyzing clathrin-coated vesicles (CCVs) from HeLa cells. siRNA knockdown of coat components and different fractionation protocols were used to obtain modified coated vesicle-enriched fractions, which were compared by stable isotope labeling of amino acids in cell culture (SILAC)-based quantitative mass spectrometry. 10 datasets were combined through principal component analysis into a "profiling" cluster analysis. Overall, 136 CCV-associated proteins were predicted, including 36 new proteins. The method identified >93% of established CCV coat proteins and assigned >91% correctly to intracellular or endocytic CCVs. Furthermore, the profiling analysis extends to less well characterized types of coated vesicles, and we identify and characterize the first AP-4 accessory protein, which we have named tepsin. Finally, our data explain how sequestration of TACC3 in cytosolic clathrin cages causes the severe mitotic defects observed in auxilin-depleted cells. The profiling approach can be adapted to address related cell and systems biological questions